Comparison of follitropin-β administered by a pen device with conventional syringe in an ART programme - A retrospective study

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 4, 2008, Pages 401-407

  Rama Raju, G A ^a   Suryanarayana, K ^a   Prakash, G Jaya ^a   Krishna, K Murali ^a  

^a Krishna IVF Clinic   (India)

Author keywords

Controlled ovarian stimulation; In vitrofertilization; Infertility; Local tolerance; Pen device; Recombinant follicle stimulating hormone

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; PROGESTERONE; RECOMBINANT FOLLITROPIN; FOLLITROPIN BETA SUBUNIT; GONADORELIN;

ADULT; ARTICLE; BIRTH RATE; DRUG DELIVERY SYSTEM; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INJECTION SITE CONTUSION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVULATION; SYRINGE; BLOOD; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; EMBRYO (ANATOMY); INSTRUMENTATION; LIVE BIRTH; MALE; OOCYTE; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; TIME;

ADULT; CHORIONIC GONADOTROPIN; DOWN-REGULATION; EMBRYO, MAMMALIAN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GONADOTROPIN-RELEASING HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; LIVE BIRTH; MALE; OOCYTES; OVARIAN FOLLICLE; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME FACTORS;

EID: 49849102948     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00931.x     Document Type: Article

References (18)

1. Howles CM, Loumaye E, Giroud D, Luyet G (1994) Multiple follicular development and ovarian steridogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study. Human Reproduction, 9, 424-430.
2. Howles CM(1996) Genetic engineering of human FSH (Gonal-F). Human Reproduction Update, 2, 172-191.
3. Harlin J, Czemiczky G, Wramsby H, Fried G (2000) Recombinant follicle-stimulating hormone in in-vitro fertilization treatment-clinical experience with follitropin alpha and follitropin beta. Human Reproduction, 15, 239-244.
4. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT (1997) Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins. Fertility and Sterility, 68, 138-142.
5. Coelingh Bennink HJ, Fauser BC, Out HJ (1998) Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group. Fertility and Sterility, 69, 19-25.
6. Daya S, Gunby J (1999) Recombinant versus urinary FSH for ovarian stimulation in assisted reproduction. Human Reproduction, 14, 2207-2215.
7. Voortman G, van de Post J, Schoemaker RC, van Gerven JMA (1999) Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregonâ ) by Pen-injector and syringe. Human Reproduction, 7, 1698-1702.
8. Devroey P, Tjandraprawira K, Mannaerts B et al. (1995) A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Human Reproduction, 10, 332-337.
9. Joris H, Nagy Z, Van de Velde H, De Vos A, Van Steiteghem A (1998) Intracytoplasmic sperm injection: laboratory set-up and injection procedure. Human Reproduction, 13(Suppl. 1), 76-86. (Pubitemid 28310442)
10. Van Steirteghem A, Nagy P, Joris H et al. (1998) Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa. Human Reproduction, 13(Suppl. 1), 134-142.
11. Nancy J, Bohannon MD (1999) Insulin delivery using pen devices - simple to use tools may help young and old alike. Postgraduate Medicine, 106, 57-68.
12. Robertson KE, Glazer NB, Campbell RK (2000) The latest development in insulin injection devices. Diabetes Educator, 26, 135-138.
13. Bohannon NJ, Ohannesian JP, Burdan AL, Holcombe JH, Zagar A (2000) Patient and physician satisfaction with the Humulin / Humalog pen, a new 3.0 ml prefilled pen device for insulin delivery. Clinical Therapeutics, 22, 1049-1067.
14. Craenmehr E, Bontje PM, Hoomans E, Voortman G, Mannaerts BMJL (2001) Follitropin-β administered by pen device has superior local tolerance compared with follitropin-a administered by conventional syringe. Reproductive Biomedicine Online, 3, 185-189.
15. Platteau P, Laurent E, Albano C et al. (2003) An open, randomized, single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alfa administered by a conventional syringe in women undergoing ovarian stimulation for IVF / ICSI. Human Reproduction, 18, 1200-1204.
16. Kettel LM, Scholl G, Bonaventura L, Pang S, Sacks P, Chantilis S (2004) Evaluation of pen device for selfadministration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Reproductive Biomedicine Online, 9, 373-380.
17. Pang S, Kaplan B, Karande V, Westphal LM, Scott R, Givens C, Sacks P (2003) Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reproductive Biomedicine Online, 7, 319-326.
18. Pang CS (2005) A pen injection device for selfadministration of recombinant follicle-stimulating hormone for fertility treatments. Expert review of medical devices, 2, 27-32.